Clinical Trial Update: CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on CD34+ selection for partially matched family or matched unrelated adult donor transplants in leukemia and lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Bone Marrow Failure
• Histiocytosis
• Immunodeficiencies
• Inborn Errors of Metabolism
• Leukemia
• Lymphoma
• Sickle Cell Disease

Drugs mentioned

• CD34+Selection

Snippet

Sponsor: New York Medical College | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED